214 related articles for article (PubMed ID: 37491944)
21. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
[TBL] [Abstract][Full Text] [Related]
22. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
[TBL] [Abstract][Full Text] [Related]
23. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
[TBL] [Abstract][Full Text] [Related]
24. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.
Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 Accelerates Osteoclastogenesis Induced by Non-Small Cell Lung Carcinoma Cells Through Self-Potentiation and VCAM1 Secretion.
Liao T; Chen W; Sun J; Zhang Y; Hu X; Yang S; Qiu H; Li S; Chu T
Cell Physiol Biochem; 2018; 50(3):1084-1099. PubMed ID: 30355915
[TBL] [Abstract][Full Text] [Related]
28. OPN N-glycosylation promoted bone destruction.
Dong M; Sun Q; Yu X; Sui L; Xu Y; Kong H; Kong Y
Oral Dis; 2023 Jul; 29(5):2154-2162. PubMed ID: 35451542
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma.
Štemberger C; Matušan-Ilijaš K; Avirović M; Bulat-Kardum L; Ivančić A; Jonjić N; Lučin K
Acta Histochem; 2014 Jan; 116(1):222-9. PubMed ID: 23992637
[TBL] [Abstract][Full Text] [Related]
31. MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.
Liao M; Peng L
Cell Mol Biol Lett; 2020; 25():22. PubMed ID: 32206066
[TBL] [Abstract][Full Text] [Related]
32. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
Huang H; Huang J; Yao J; Li N; Yang Z
J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
[TBL] [Abstract][Full Text] [Related]
34. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?
Ayan AK; Erdemci B; Orsal E; Bayraktutan Z; Akpinar E; Topcu A; Turkeli M; Seven B
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):102-6. PubMed ID: 26521996
[TBL] [Abstract][Full Text] [Related]
35. [Expression of FGF-2 and osteopontin in non-small cell lung cancer].
Li T; Zhou J; Deng Z; Fu C; Jiang H; Gao Z; Wang J; Ren H; Wang P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1114-9. PubMed ID: 19952401
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
[TBL] [Abstract][Full Text] [Related]
39. Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells.
Kang CG; Lee HJ; Kim SH; Lee EO
J Nat Prod; 2016 Jan; 79(1):156-60. PubMed ID: 26681550
[TBL] [Abstract][Full Text] [Related]
40. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1.
Huang W; Yan Y; Liu Y; Lin M; Ma J; Zhang W; Dai J; Li J; Guo Q; Chen H; Makabel B; Liu H; Su C; Bi H; Zhang J
Signal Transduct Target Ther; 2020 Apr; 5(1):39. PubMed ID: 32317629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
